ClinVar Miner

Submissions for variant NM_001845.6(COL4A1):c.1807C>T (p.Pro603Ser)

gnomAD frequency: 0.00002  dbSNP: rs747585517
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genomic Research Center, Shahid Beheshti University of Medical Sciences RCV000625809 SCV000746366 likely pathogenic Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome 2017-12-03 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001529466 SCV002205905 uncertain significance not provided 2025-01-08 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 603 of the COL4A1 protein (p.Pro603Ser). This variant is present in population databases (rs747585517, gnomAD 0.002%). This missense change has been observed in individual(s) with multi-cystic dysplastic kidney (PMID: 31230195). ClinVar contains an entry for this variant (Variation ID: 522668). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt COL4A1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics, Fulgent Genetics RCV005004277 SCV005632426 uncertain significance Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant 2023-12-28 criteria provided, single submitter clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001529466 SCV001742977 uncertain significance not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001529466 SCV001808406 uncertain significance not provided no assertion criteria provided clinical testing
Yale Center for Mendelian Genomics, Yale University RCV001849420 SCV002106634 likely pathogenic Congenital anomaly of kidney and urinary tract 2019-06-22 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.